Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2727]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
ESMO 2017 roundup with Dr Bishal Gyawali (1/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
ESMO 2017 roundup with Dr Bishal Gyawali (2/2)
Dr Bishal Gyawali - Nagoya University, Nagoya, Japan
ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )
11 Sep 2017
Small node-negative breast cancers may retain aggressive characteristics
Dr Konstantinos Tryfonidis - European Organisation for Research and Treatment...
Small node-negative breast cancers may retain aggressive characteristics ( Dr Konstantinos Tryfonidis - European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium )
9 Sep 2017
Panitumumab triplet therapy in colorectal cancer
Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany
Panitumumab triplet therapy in colorectal cancer ( Prof Michael Geißler - Klinikum Esslingen, Esslingen am Neckar, Germany )
9 Sep 2017
New treatments for acute myeloid leukaemia and lymphoid leukaemia
Dr Hugo Fernandez - Memorial Healthcare System, Hollywood, Florida, USA
New treatments for acute myeloid leukaemia and lymphoid leukaemia ( Dr Hugo Fernandez - Memorial Healthcare System, Hollywood, Florida, USA )
21 Jul 2017
Celebrating a 10 year partnership: ecancer and the IEO
Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017
Implementation of a wait and see program for rectal cancer
Prof André D'Hoore - University of Leuven, Leuven, Belgium
Implementation of a wait and see program for rectal cancer ( Prof André D'Hoore - University of Leuven, Leuven, Belgium )
5 Jul 2017
Precision medicine enabled histology agnostic development of immunotherapeutics
Dr Roy Baynes - Merck Research Laboratories, Rahway, USA
Precision medicine enabled histology agnostic development of immunotherapeutics ( Dr Roy Baynes - Merck Research Laboratories, Rahway, USA )
4 Jul 2017
Genomic predictors of treatment response in prostate cancer
Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada
Genomic predictors of treatment response in prostate cancer ( Dr Robert Bristow - Princess Margaret Cancer Centre, Toronto, Canada )
4 Jul 2017
Lenalidomide with CD19 antibodies in L-MIND
Dr Kami Maddocks - Ohio State University, Columbus, USA
Lenalidomide with CD19 antibodies in L-MIND ( Dr Kami Maddocks - Ohio State University, Columbus, USA )
25 Jun 2017
Triplet therapy for all comers in the CLL-BAG trial
Dr Paula Cramer – University of Cologne, Cologne, Germany
Triplet therapy for all comers in the CLL-BAG trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
24 Jun 2017
FDG-PET guidance allows substantial chemoreduction in Hodgkin lymphoma
Dr Peter Borchmann - Uniklinik Koeln, Cologne, Germany
FDG-PET guidance allows substantial chemoreduction in Hodgkin lymphoma ( Dr Peter Borchmann - Uniklinik Koeln, Cologne, Germany )
24 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation